bpc 157 otc BPC-157 Rapid BPC-157: Experimental Peptide Creates Risk

Subcutaneous Injection Injection into the fatty tissue layer beneath the skin

There is no published human safety or efficacy data, no reproductive- or developmental-toxicology research, no studies in hepatic or renal impairment, and no drug-interaction studies

It doesnt function like caffeine, nitric oxide boosters, or stimulants

USP Chapter 797 governs beyond-use dating and sterility standards for these preparations (PMID: 19710449)

The starting dose for severe deficiency is typically 1500mcg (the full dose of the 1ml vial) given daily or on alternate days for 1 to 2 weeks, or until haematological remission is achieved